Mads Nikolaj Behrndt-Eriksen
Chief Financial Officer and General Manager · Hemab Therapeutics Holdings, Inc.
Individual
- 2026
- May 4, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mads Nikolaj Behrndt-Eriksen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $55.46M in COAG purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mads Nikolaj Behrndt-Eriksen?
Mads Nikolaj Behrndt-Eriksen is a corporate insider, tracked as Chief Financial Officer and General Manager of Hemab Therapeutics Holdings, Inc. (COAG). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Mads Nikolaj Behrndt-Eriksen last file a Form 4?
The only primary Form 4 on record is dated 4 May 2026.